Catalyst Wire Dossier Catalyst Wire Dossier

Calcipotriene 0.005% Foam

calcipotriene · Mayne Pharma International Pty Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Calcipotriene 0.005% Foam, covering 2018-05-11 to 2018-05-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis [Phase 1]

See pricing